TKPHF (Takeda Pharmaceutical Co) Long-Term Debt : $30,969 Mil (As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Takeda Pharmaceutical Co Long-Term Debt?

Takeda Pharmaceutical Co's Long-Term Debt for the quarter that ended in Sep. 2024 was $30,969 Mil.

Takeda Pharmaceutical Co's quarterly Long-Term Debt increased from Mar. 2024 ($29,879 Mil) to Jun. 2024 ($31,941 Mil) but then declined from Jun. 2024 ($31,941 Mil) to Sep. 2024 ($30,969 Mil).

Takeda Pharmaceutical Co's annual Long-Term Debt declined from Mar. 2022 ($34,926 Mil) to Mar. 2023 ($30,245 Mil) and declined from Mar. 2023 ($30,245 Mil) to Mar. 2024 ($29,879 Mil).

Takeda Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Takeda Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Long-Term Debt Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

41,855.67

42,440.26

34,925.86

30,245.48

29,879.47

Takeda Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															29,790.41	29,822.39	29,879.47	31,941.23	30,968.65

Takeda Pharmaceutical Co (OTCPK:TKPHF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Takeda Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

TAK:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.